Abbott Laboratories acquires Facet Biotech - MarketLine Financial Deals

Abbott Laboratories acquires Facet Biotech

Abbott Laboratories acquires Facet Biotech - MarketLine Financial Deals
Abbott Laboratories acquires Facet Biotech
Published Apr 21, 2010
5 pages — Published Apr 21, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Abbott Laboratories, through its wholly-owned subsidiary Amber Acquisition, Inc., has acquired all outstanding shares of common stock of Facet Biotech Corporation, a biotechnology company.

  
Source:
Document ID
MA21010_100311
Country
Ticker
ABT=US
Ticker
FACT=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Abbott Laboratories acquires Facet Biotech" Apr 21, 2010. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Abbott-Laboratories-acquires-Facet-Biotech-2052-27089>
  
APA:
MarketLine Financial Deals. (2010). Abbott Laboratories acquires Facet Biotech Apr 21, 2010. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Abbott-Laboratories-acquires-Facet-Biotech-2052-27089>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.